Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
83.00    0.40 (0.48%)
Bid:
82.00
Ask:
84.00
Spread: 2.00 (2.439%)
Market Cap: £87.21m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

Trading Update

19 May 2025 07:00

RNS Number : 0996J
SDI Group PLC
19 May 2025
 

SDI Group plc

("SDI", the "Company", or the "Group")

Trading Update

19 May 2025 - SDI Group plc, the buy and build group, focused on companies which design and manufacture specialist lab equipment, industrial & scientific sensors and industrial & scientific products, provides a trading update for the year ended 30 April 2025 ("FY25").

The Company expects full year results to be in line with current market expectations1, following strong trading over the second half of FY25, offsetting the slow start to the financial year.

SDI has continued to demonstrate solid cash generation during FY25 and retains sufficient headroom within existing debt facilities to support the Group's acquisition strategy. At 30 April 2025 the Group had net debt of £13.8m and £9.9m of undrawn bank facility (excluding the £5m accordion option) and a further £0.6m of deferred consideration payable relating to previous acquisitions.

The Group has a robust order book, buoyed by an uptick in orders in Q4 FY25, and looks forward to providing a further update at the full year results in late-July/early August.

Operational Update

The Group strategy remains to drive growth organically as well as expanding the business through strategic acquisitions that complement the existing portfolio, where synergies including cross-sell opportunities can be leveraged.

Several businesses within the portfolio demonstrated strong performance in the second half. Monmouth Scientific experienced increased demand for its fume cabinets, while Safelab Systems successfully fulfilled a substantial order that had been deferred from the first half of the year. Chell saw increased demand for its DAQ product range, and Sentek benefited from positive market trends in pH sensors. Atik Cameras had an excellent FY25, with demand for its cameras normalising following a slow FY24, and both Graticules and MPB delivered strong overall performances across FY25.

Order intake increased during the second half of the year, driven by key contract wins across several businesses. These included a notable win for Atik Cameras from a professional astronomy customer, strong clean room order intake at Monmouth and a key agreement for Sentek with a prominent OEM. LTE Scientific and Applied Thermal Control both successfully launched new products and Sentek completed a successful trial of a novel pH sensor for a UK customer that is expected to produce a new revenue stream.

Over the course of FY25, the Group has acquired two businesses: InspecVision, a designer and manufacturer of computer vision-based measurement systems for industrial applications, acquired in October 2024, and Collins Walker, a designer and manufacturer of electric boilers, acquired in April 2025. InspecVision is trading as a standalone business within the portfolio, whilst the integration of Collins Walker into Applied Thermal Control has begun. InspecVision traded positively, as expected, post-acquisition. Due to the Collins Walker acquisition being completed in April 2025, as expected, it did not have a significant impact on FY25.

Post year end, InspecVision was awarded the prestigious King's Award for Enterprise in the category of International Trade, reflecting its quality as a successful and profitable UK engineering business operating in a unique, but critical, niche.

Tariffs

Approximately 10% of revenues in FY25 were generated from sales directly to the US, and the introduction of tariffs on products sold to the US is not expected to have a material impact on the Group.

Stephen Brown, CEO of SDI Group commented:

"The second half of the year has finished strongly, with momentum continuing into FY26. We are seeing some notable performances from businesses across our portfolio and good demand for their niche highly specialised scientific and industrial products, despite the global economic uncertainty. This is testament to the quality businesses within our portfolio and their diversified geographical and sectoral customer base."

1 Analysts from SDI's broker Cavendish Capital Markets Limited, and from Progressive Equity Research regularly provide research on the Company, accessible from SDI's website, and the Group considers the average of their forecasts to represent market expectations which for FY25 are Sales of £66.5m and Adjusted Profit Before Tax of £8.4m.

 

Enquiries:

SDI Group plc

Stephen Brown, Chief Executive Officer

Amitabh Sharma, Chief Financial Officer

+44 (0)1223 727144

www.sdigroup.com

 

Cavendish Capital Markets Ltd (NOMAD & broker)

Ed Frisby / Seamus Fricker - Corporate Finance

Andrew Burdis / Sunila de Silva - ECM

 

 

+44 (0)20 7220 0500

Vigo Consulting (Financial Communications)

Tim McCall / Rozi Morris / Fiona Hetherington

 

+44 (0)20 7390 0230

SDIGroup@vigoconsulting.com 

 

About SDI Group plc

SDI Group plc is a group of small to medium size companies with specialist industrial and scientific products in growth sector niches which help solve customers' key challenges. It specialises in the acquisition and development of companies that design and manufacture specialist products for use in lab equipment, industrial & scientific sensors and industrial & scientific products.

Its portfolio of businesses supplies the life sciences, healthcare, plastics and packaging, manufacturing, precision optics and measurement instrumentation markets.

SDI aims to continue its growth through driving the organic growth of its portfolio companies and by the acquisition of complementary technology businesses with established reputations in global markets.

For more information, please see: www.SDIGroup.com

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGMKNVZGKZM
Date   Source Headline
10th Jun 20267:00 amRNSDirectorate change
21st May 20267:00 amRNSTrading Update
11th May 20261:00 pmRNSDirectorate change
10th Apr 20264:40 pmRNSHolding(s) in Company
9th Apr 20265:05 pmRNSHolding(s) in Company
20th Mar 202610:45 amRNSHolding(s) in Company
17th Mar 20267:00 amRNS-RNews from Portfolio Companies
17th Mar 20267:00 amRNS-RNews from Portfolio Companies
13th Mar 20261:41 pmRNSHolding(s) in Company
2nd Mar 20266:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20263:45 pmRNSHolding(s) in Company
13th Feb 20267:00 amRNSAcquisition of PRP Optoelectronics
3rd Dec 20257:00 amRNSInterim Results
17th Nov 20257:00 amRNSNotice of Results and Investor Presentation
7th Oct 20254:49 pmRNSAIM Rule 17 and Schedule 2(g) Update
6th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
25th Sep 20257:00 amRNSGrant of Share Option Awards
24th Sep 20252:30 pmRNSResult of AGM
24th Sep 20257:00 amRNSAGM Trading Update
19th Sep 20253:31 pmRNSHolding(s) in Company
21st Aug 20257:00 amRNSPosting of Annual Report and Notice of AGM
30th Jul 20257:00 amRNSFinal Results
21st Jul 20257:00 amRNSNotice of Results and Investor Presentation
26th Jun 20252:14 pmRNSAIM Rule 17 and Schedule 2(g) Update
6th Jun 20257:00 amRNSAcquisition of Severn Thermal Solutions
19th May 20257:00 amRNSTrading Update
6th May 20257:00 amRNS-RInspecVision awarded King's Award for Enterprise
11th Apr 20253:00 pmRNSHolding(s) in Company
4th Apr 20251:55 pmRNSDirector / PDMR Shareholding
4th Apr 20257:00 amRNSAcquisition of Collins Walker
20th Mar 20257:00 amRNS-RNews from Portfolio Companies
14th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSNotice of Results and Investor Presentation
30th Oct 20247:00 amRNSAcquisition of InspecVision
14th Oct 202410:00 amRNSHoldings in Company
7th Oct 20245:00 pmRNSHolding(s) in Company
27th Sep 20247:00 amRNSShare Option Awards
26th Sep 20243:00 pmRNSDirector/PDMR Shareholding
26th Sep 20241:05 pmRNSResult of AGM
26th Sep 20247:00 amRNSAGM Trading Update
28th Aug 20247:00 amRNSPosting of Annual Report & Accounts & AGM Notice
30th Jul 20247:00 amRNSFinal Results
23rd Jul 20241:00 pmRNSNotice of Results and Investor Presentation
4th Jul 202411:45 amRNSHolding(s) in Company
3rd Jul 20244:25 pmRNSHolding(s) in Company
23rd May 202411:30 amRNSHolding(s) in Company
20th May 20247:00 amRNSTrading Update
3rd Apr 20242:15 pmRNSExercise of Share Options and Total Voting Rights
18th Mar 202412:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.